ResMed Inc. (RSMDF)

Market Cap	37.27B +7.4%
Revenue (ttm)	5.40B +9.6%
Net Income	1.49B +19.0%
EPS	10.11 +19.4%
Shares Out	n/a
PE Ratio	25.08
Forward PE	22.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	13,077
Open	28.10
Previous Close	28.10
Day's Range	28.10 - 28.10
52-Week Range	11.91 - 37.91
Beta	0.88
RSI	68.13
Earnings Date	Jan 29, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSMDF

Financial Performance

In fiscal year 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.